Free Trial

Surmodics (SRDX) Earnings Date, Estimates & Call Transcripts

Surmodics logo
$39.96 -0.05 (-0.12%)
(As of 12/17/2024 05:27 PM ET)

Surmodics Latest Earnings Summary

Actual EPS
(Nov. 6)
-$0.13 Beat By $0.14
Consensus EPS
(Nov. 6)
-$0.27

Surmodics announced Q3 2024 earnings on November 6, 2024, reporting an EPS of -$0.13, which beat analysts' consensus estimates of -$0.27 by $0.14. Quarterly revenue was reported to be $33.23 million, above the consensus estimate of $30.69 million. With a trailing EPS of -$0.81, Surmodics' earnings are expected to grow 388.24% next year, from $0.17 to $0.83 per share.

Get Surmodics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Surmodics and other key companies, straight to your inbox.

Sign Up
Skip Charts & View Estimated and Actual Earnings Data

SRDX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

SRDX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Surmodics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20242-$0.31-$0.29-$0.30 
Q2 20242-$0.36-$0.36-$0.36 
Q3 20242-$0.31-$0.29-$0.30 
Q4 20242-$0.27-$0.25-$0.26 
FY 20248-$1.25-$1.19-$1.22 
Q1 20252-$0.11-$0.09-$0.10 
Q2 20252-$0.08$0.01-$0.04 
Q3 20252$0.09$0.10$0.10 
Q4 20252$0.17$0.21$0.19 
FY 20258$0.07$0.23$0.15 
Q1 20261$0.22$0.22$0.22 
Q2 20261$0.13$0.13$0.13 
Q3 20261$0.20$0.20$0.20 
Q4 20261$0.22$0.22$0.22 
FY 20264$0.77$0.77 $0.77

Surmodics Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/6/2024--$0.27-$0.13+$0.14-$0.02$30.69M$33.23M
7/31/2024Q3 2024-$0.31-$0.27+$0.04-$0.01$30.32M$30.34M
5/1/2024Q2 2024-$0.36$0.07+$0.43$0.12$28.79M$31.96M
11/8/2023Q4 2023$0.16$0.53+$0.37$0.59$26.00M$27.97M
8/2/2023Q3 2023-$0.46$0.52+$0.98$0.52$26.70M$52.48M
4/26/2023Q2 2023-$0.49-$0.40+$0.09-$0.25$25.99M$27.20M
2/6/2023Q4 2022-$0.63-$0.50+$0.13-$0.44$24.19M$24.93M

Surmodics Earnings - Frequently Asked Questions

Surmodics (NASDAQ:SRDX) last announced its quarterly earning data on Wednesday, November 6, 2024. Learn more on SRDX's earnings history.

In the previous quarter, Surmodics (NASDAQ:SRDX) reported ($0.13) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.27) by $0.14. Learn more on analysts' earnings estimate vs. SRDX's actual earnings.

Surmodics (NASDAQ:SRDX) has a recorded annual revenue of $126.08 million.

Surmodics (NASDAQ:SRDX) has a recorded net income of -$11.54 million. SRDX has generated -$0.81 earnings per share over the last four quarters.

Surmodics's earnings are expected to grow from $0.17 per share to $0.83 per share in the next year, which is a 388.24% increase.

More Earnings Resources from MarketBeat



This page (NASDAQ:SRDX) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners